ADCT - ADC Therapeutics SA
1.27
-0.020 -1.575%
Share volume: 115,944
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.29
-0.02
-0.02%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 05-06-2024 | 08-06-2024 | 11-07-2024 | 05-06-2024 | 08-06-2024 | 11-07-2024 | 03-27-2025 | |
Total revenue | 18.992 M | 19.283 M | 14.493 M | 18.053 M | 17.410 M | 18.464 M | 16.910 M | |
Cost of revenue | 0.000 | 1.132 M | 208.000 K | 2.510 M | 1.217 M | 851.000 K | 1.371 M | |
Gross profit | 18.992 M | 18.151 M | 14.285 M | 15.543 M | 16.193 M | 17.613 M | 15.539 M | |
-4.43% | -21.30% | 8.81% | 4.18% | 8.77% | -11.78% | |||
Operating expenses | 53.878 M | 43.344 M | 36.704 M | 37.766 M | 34.533 M | 42.504 M | 36.724 M | |
Selling general and admin | 15.503 M | 12.002 M | 9.624 M | 12.031 M | 10.238 M | 10.002 M | 9.623 M | |
Research and development | 38.375 M | 31.342 M | 27.080 M | 25.735 M | 24.295 M | 32.502 M | 27.101 M | |
Total expenses | 69.229 M | 57.800 M | 50.434 M | 49.156 M | 45.234 M | 53.177 M | 47.975 M | |
-16.51% | -12.74% | -2.53% | -7.98% | 17.56% | -9.78% | |||
Operating income | -50.210 M | -39.649 M | -36.149 M | -33.613 M | -29.041 M | -35.564 M | -32.436 M | |
Ebit | -49.377 M | -44.716 M | -35.289 M | -36.208 M | -26.287 M | -33.940 M | -21.762 M | |
Pretax income | -57.493 M | -52.653 M | -45.402 M | -45.756 M | -35.713 M | -43.619 M | -31.048 M | |
-8.42% | -13.77% | 0.78% | -21.95% | 22.14% | -28.82% | |||
Income tax | 518.000 K | -4.498 M | -85.000 K | 163.000 K | 234.000 K | 90.000 K | -321.000 K | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -59.374 M | -48.922 M | -46.726 M | -46.606 M | -36.544 M | -43.969 M | -30.727 M | |
17.60% | 4.49% | 0.26% | 21.59% | -20.32% | 30.12% |